Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Cyclophosphamide vs Doxorubicin in Elderly STS
NCT04656262Phase 3Terminated
- Sponsor
- Istituto Oncologico Veneto
- Start
- Sep 2018
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in soft tissue sarcoma (STS), sponsored by Istituto Oncologico Veneto. Started Sep 2018; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04656262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04656262.